Total Payments
$2,677
2023 Payments
$49.89
Companies
40
Transactions
167
Medicare Patients
1,811
Medicare Billing
$151,106
Payment Breakdown by Category
Food & Beverage$2,651 (99.0%)
Education$25.65 (1.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,651 | 164 | 99.0% |
| Education | $25.65 | 3 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $401.97 | 23 | $0 (2019) |
| Novo Nordisk Inc | $396.79 | 18 | $0 (2023) |
| Lilly USA, LLC | $245.95 | 9 | $0 (2022) |
| Amgen Inc. | $240.44 | 10 | $0 (2019) |
| Astellas Pharma US Inc | $153.69 | 8 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $107.86 | 9 | $0 (2019) |
| AbbVie Inc. | $99.44 | 6 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $91.43 | 11 | $0 (2019) |
| PFIZER INC. | $85.35 | 7 | $0 (2019) |
| GlaxoSmithKline, LLC. | $84.77 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $49.89 | 3 | AbbVie Inc. ($35.40) |
| 2022 | $122.09 | 1 | Lilly USA, LLC ($122.09) |
| 2021 | $13.09 | 1 | AbbVie Inc. ($13.09) |
| 2019 | $532.23 | 31 | Novo Nordisk Inc ($175.71) |
| 2018 | $907.12 | 72 | AstraZeneca Pharmaceuticals LP ($110.50) |
| 2017 | $1,052 | 59 | AstraZeneca Pharmaceuticals LP ($240.42) |
All Payment Transactions
167 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 08/08/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $122.09 | General |
| Category: Diabetes | ||||||
| 11/09/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $120.19 | General |
| Category: Diabetes | ||||||
| 06/13/2019 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Neuroscience | ||||||
| 06/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Diabetes | ||||||
| 06/12/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: Diabetes | ||||||
| 06/06/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: UROLOGY | ||||||
| 06/05/2019 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 05/24/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/14/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Bone Health | ||||||
| 05/01/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $10.41 | General |
| Category: Diabetes | ||||||
| 04/30/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Anemia | ||||||
| 04/18/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Obesity | ||||||
| 04/17/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Neuroscience | ||||||
| 04/16/2019 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Endocrinology | ||||||
| 04/11/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 04/04/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Hypertriglyceridemia | ||||||
| 03/28/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: Central Nervous System (CNS) | ||||||
| 03/20/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes | ||||||
| 03/14/2019 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 498 | 582 | $79,485 | $44,388 |
| 2022 | 12 | 471 | 566 | $83,173 | $42,178 |
| 2021 | 10 | 412 | 553 | $82,048 | $38,519 |
| 2020 | 10 | 430 | 547 | $73,776 | $26,021 |
Total Patients
1,811
Total Services
2,248
Medicare Billing
$151,106
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 92 | 92 | $15,180 | $11,050 | 72.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 62 | 89 | $20,470 | $10,310 | 50.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 147 | $24,990 | $10,194 | 40.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $8,845 | $7,897 | 89.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 37 | $4,440 | $1,889 | 42.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,275 | $1,079 | 84.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $725.00 | $686.00 | 94.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 30 | 30 | $1,050 | $510.60 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 18 | $450.00 | $441.00 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 15 | 22 | $1,320 | $209.44 | 15.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 68 | 74 | $740.00 | $122.22 | 16.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 174 | $29,580 | $12,869 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 76 | 111 | $25,530 | $12,064 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 83 | 83 | $13,695 | $10,361 | 75.7% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 29 | 29 | $5,945 | $2,203 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 28 | $3,360 | $1,622 | 48.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $1,360 | $1,165 | 85.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 38 | $950.00 | $935.00 | 98.4% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2022 | 14 | 14 | $560.00 | $411.19 | 73.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $275.00 | $271.00 | 98.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 22 | $1,320 | $201.40 | 15.3% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 22 | 23 | $230.00 | $45.77 | 19.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 16 | $368.00 | $30.96 | 8.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 164 | 289 | $49,130 | $21,717 | 44.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 71 | 71 | $11,715 | $9,009 | 76.9% |
About Dr. Stephen Dewey, MD
Dr. Stephen Dewey, MD is a Family Medicine healthcare provider based in Fishers, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265415574.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Dewey, MD has received a total of $2,677 in payments from pharmaceutical and medical device companies, with $49.89 received in 2023. These payments were reported across 167 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($2,651).
As a Medicare-enrolled provider, Dewey has provided services to 1,811 Medicare beneficiaries, totaling 2,248 services with total Medicare billing of $151,106. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Fishers, IN
- Active Since 11/22/2005
- Last Updated 06/17/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1265415574
Products in Payments
- FARXIGA (Drug) $274.20
- Ozempic (Drug) $153.95
- Victoza (Drug) $145.36
- BYDUREON (Drug) $127.77
- MOUNJARO (Drug) $122.09
- MYRBETRIQ (Drug) $110.13
- Repatha (Biological) $108.87
- Aimovig (Biological) $88.54
- TRULICITY (Drug) $79.60
- Trintellix (Drug) $75.26
- RELISTOR ORAL (Drug) $60.47
- TOUJEO (Drug) $58.13
- Saxenda (Drug) $55.12
- Synthroid (Drug) $50.95
- VRAYLAR (Drug) $50.88
- Myrbetriq (Drug) $43.56
- Belviq (Drug) $43.32
- CHANTIX (Drug) $37.50
- LYRICA (Drug) $35.50
- SOLIQUA (Drug) $34.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fishers
Justin Smith, Md, MD
Family Medicine — Payments: $5,205
Family Medicine $5,205
Aaron Carlisle, M.d, M.D
Family Medicine — Payments: $5,144
Family Medicine $5,144
David Vickery, Md, MD
Family Medicine — Payments: $4,620
Family Medicine $4,620
Oula Alhabian, Md, MD
Family Medicine — Payments: $4,429
Family Medicine $4,429
Kristen Blume, M.d, M.D
Family Medicine — Payments: $3,674
Family Medicine $3,674
Michael Emmons, Do, DO
Family Medicine — Payments: $3,076
Family Medicine $3,076